Two decades of clinical experience with immunomodulatory treatments for multiple sclerosis point to distinct immunological pathways that drive disease relapses and progression. In light of this, we discuss our current understanding of multiple sclerosis immunopathology...

Please reload

Featured Posts

Neuroinflammation - using big data to inform clinical practice

November 24, 2016

1/1
Please reload

Recent Posts
Please reload

Archive